Jacques Rouanet

9PUBLICATIONS
43CO-AUTHORS
Tumour immunologyMolecular targetsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 11, 2025
Impact of melanoma histological regression on first-line immunotherapy response in stage-IV disease.

Jean-Baptiste Such, Sandrine Mansard, Mélissa Zlobecki

|Sep 03, 2025
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model.

Marine Delmas, Benjamin Chaussin, Nathan Harismendy

|Sep 02, 2025
Imatinib-Induced Reactive Angioendotheliomatosis: A Paradoxical Pro-Angiogenic Case.

Elise Lang, Olivier Tournilhac, Carole Chevenet

|Apr 10, 2024
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients.

Didier Bessis, Anne-Claire Bursztejn, Fanny Morice-Picard

|Jul 29, 2023
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).

Charlée Nardin, Aymeric Hennemann, Kadiatou Diallo

|Nov 13, 2021
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials.

Aurélie Rondon, Jacques Rouanet, Françoise Degoul

Pageof 2

Frequent Collaborators

3 joint publications

Sophie Besse

3 joint publications

Michel D'Incan

3 joint publications

Françoise Degoul

2 joint publications

Valentin Benboubker